Anticancer Effects Of Thymoquinone In Ovarian Cancer Models: A Systematic Review
International Journal of Drug Delivery Technology · 10.06.2026 · 16 (53s)
DOI: 10.25258/ijddt.16.53s.34 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 10.06.2026. Verfasst von Subhashini Y und 4 weiteren Autor:innen.
Abstract (Originalsprache)
This systematic review evaluates the anticancer effects of thymoquinone in ovarian cancer models. A systematic search of PubMed from inception through January 31, 2025, identified 17 records. After screening and full-text assessment, nine studies met inclusion criteria: ovarian cancer model, thymoquinone intervention, and PubMed indexing. Included studies comprised seven in vitro investigations and two studies with both in vitro and in vivo components. Cell lines examined included A2780, OVCAR3, SK-OV-3, Caov-3, and ID8 mouse models. Thymoquinone demonstrated dose- and timedependent cytotoxicity across models. Mechanistic analyses revealed apoptosis induction through Bax upregulation and Bcl-2 downregulation, reactive oxygen species generation, and mitochondrial membrane potential disruption. Combination studies with cisplatin or doxorubicin showed synergistic effects. However, two mouse studies reported paradoxical tumor-promoting effects with thymoquinone monotherapy in vivo, highlighting microenvironmental complexity. Evidence quality ranged from low to high, with most studies limited to single replicates and in vitro settings. While thymoquinone exhibits promising anticancer mechanisms in ovarian cancer models, the limited scope of current evidence and translational concerns necessitate rigorous preclinical validation before clinical consideration.
Zitieren
APA
Y, S., A, S. K., Swarnalatha, J. C., ., R., & S, S. (2026). Anticancer Effects Of Thymoquinone In Ovarian Cancer Models: A Systematic Review. International Journal of Drug Delivery Technology, 16(53s). https://doi.org/10.25258/ijddt.16.53s.34
Vancouver
Y S, A SK, Swarnalatha JC, . R, S S. Anticancer Effects Of Thymoquinone In Ovarian Cancer Models: A Systematic Review. International Journal of Drug Delivery Technology. 2026;16(53s). doi:10.25258/ijddt.16.53s.34
BibTeX
@article{Y2026,
author = {Y, Subhashini and A, Sasi Kumar and Swarnalatha, J C and ., Radhika and S, Subamalan},
title = {Anticancer Effects Of Thymoquinone In Ovarian Cancer Models: A Systematic Review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {53s},
doi = {10.25258/ijddt.16.53s.34}
}
EUVIMED